跳至主要内容
临床试验/JPRN-UMIN000045594
JPRN-UMIN000045594已完成2 期

A phase II study of collagen peptide-containing beverage during chemoradiotherapy for patients with head and neck cancer - A phase II study of collagen peptide-containing beverage during chemoradiotherapy for patients with head and neck cancer

Shizuoka Cancer Center0 个研究点目标入组 33 人开始时间: 2021年9月29日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • i.Patients who are taking supplement or drugs containing collagen peptide, and who will continue to take them throughout the chemotherapy ii.Patients who will receive palliative chemoradiotherapy iii.Women who are pregnant, contemplating pregnancy or amid breast-feeding iv.Mental disorders which is considered inappropriate for inclusion in the study v.Protein intake restriction vi.Hypersensitivity to the element of V CRESC vii.Unable to take V CRESC per oral viii.Any other cases who are regarded as inadequate for study enrollment by the investigator

研究者

相似试验